Implantica
45.55 SEK
-0.98 %
Less than 1K followers
IMP A SDB
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.98 %
+7.81 %
-7.79 %
-9.08 %
-14.86 %
+63.85 %
+136.26 %
-59.90 %
-52.83 %
Implantica operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes implantable medical instruments, which are also used for the treatment of diseases affecting the esophagus. In addition to the main business, related ancillary services are offered, particularly focused on eHealth. The business is operated globally with the largest presence in North America and Europe.
Read moreMarket cap
53.9B SEK
Turnover
230.61K SEK
Revenue
22.39M
EBIT %
-990.01 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
22/5
2026
Interim report Q1'26
10/6
2026
General meeting '26
21/8
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
Implantica announces landmark RefluxStop[® ]study of 602 patients across 22 European centers, with up to 6.75-year follow-up, published in Nature's Scientific Reports
Implantica tillkännager den banbrytande RefluxStop[®]-studien med 602 patienter från 22 europeiska center och upp till 6,75 års uppföljning, publicerad i Nature's Scientific Reports
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
